Clinical Decision Support Systems Market Worth $791.25 Million by 2024: Grand View Research, Inc.

SAN FRANCISCO, March 28, 2018 /PRNewswire/ --

The global clinical decision support systems (CDSS) market size is estimated to reach USD 791.25 million by 2024, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.7% during the forecast period. Surging demand for quality care is one of the primary factors augmenting the market. Constant lookout for reliable technology solutions by care providers is also expected to work in favor of the market. Growing interest in enhanced medical care and efficient decision-making is projected to fuel adoption of CDSS and EHR. 

     (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )

CDSS industry includes products that provide knowledge-based and evidence-based solutions to practitioners. Decision support in critical health situation proves to be of significant importance. Furthermore, these systems analyze patient medical records and provide a list of possible solutions from which the most appropriate is to be selected.

Easy compatibility and interoperability of systems with different platforms have enhanced growth prospects of the market. Collaborative efforts of researchers and software developers to make medical knowledge available to users are anticipated to contribute towards lucrative revenue generation over the forecast period. Furthermore, collaborations intended by market participants for availing licensed product platforms for CDSS is likely to influence the growth of the market positively.

Browse full research report with TOC on "Clinical Decision Support Systems (CDSS) Market Size, Share & Trends Analysis Report By Product, By Application (Allery Alert, Dosing Support), By Delivery Mode (On-premise, Cloud, Web), By Component, And Segment Forecasts, 2013 - 2024" at: https://www.grandviewresearch.com/industry-analysis/clinical-decision-support-system-market

Further Key Findings From the Report Suggest: 

• Standalone CDSS accounted for the largest share of market revenue in 2016 owing to its low cost. The segment is estimated to hold approximately 36.0% of the overall market by 2024
• The CDSS integrated with CPOE segment is poised experience noteworthy growth over the coming years due to rapid adoption of healthcare IT solutions by clinicians
• Drug allergy alerts made the highest contribution to market revenue generation in 2016. The segment is expected to expand at a CAGR of 6.4% between 2017 and 2024
• Domicile of a large number of key players and high adoption of advanced technologies are anticipated to contribute to the dominance of North America. However, Asia Pacific is estimated to witness the highest CAGR of 7.8% during the forecast period
• Key players operating in this industry include Agfa healthcare; McKesson Corporation; NextGen Healthcare Information Systems; Medical Information Technology Inc; Carestream Health Inc.; AthenaHealth; Philips Healthcare; Wolters Kluwer NU; Cerner Corporation; and Siemens Healthineers. Collaboration with IT companies to develop innovative products and enhance existing platforms is likely to help key players to stay ahead in the market.

Browse related reports by Grand View Research: 

• MicroRNA Market - The global microRNA market worth is expected to exceed USD 1.7 billion by 2024 and is estimated to grow at a CAGR of over 18% from 2016 to 2024. 
  
• Bioinformatics Market - The Global bioinformatics market size was valued at USD 3.51 billion in 2013. Growing demand in the process of novel drug research.
  
• eHealth Market - The global eHealth market size was valued at USD 85.44 billion in 2014 and is expected to increase at the rate of 15.8% over the forecast period. 
  
• Healthcare Payer BPO Market - The Global healthcare payer BPO market size was valued at USD 15,084.6 million in 2014 and is expected to grow at CAGR of over 10% over the forecast period.

Grand View Research has segmented global clinical decision support systems (CDSS) market on the basis of product, application, delivery mode, component, and region: 

• Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2013 - 2024) 
  • Standalone CDSS
  • Integrated CPOE with CDSS
  • Integrated E.H.R. with CDSS
  • Integrated CDSS with CPOE & E.H.R.
• Clinical Decision Support Systems Application Outlook (Revenue, USD Million, 2013 - 2024) 
  • Drug-drug interactions
  • Drug allergy alerts
  • Clinical reminders
  • Clinical guidelines
  • Drug dosing support
  • Others
• Clinical Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2013 - 2024) 
  • Web Delivery
  • Cloud Delivery
  • On Premises Delivery
• Clinical Decision Support Systems Component Outlook (Revenue, USD Million, 2013 - 2024) 
  • Hardware
  • Software
  • Services
• Clinical Decision Support Systems Regional Outlook (Revenue, USD Million, 2013 - 2024) 
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • Middle East and Africa (MEA)
    • South Africa

Read Our Blog By Grand View Research: https://www.grandviewresearch.com/blogs/healthcare

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com